Lisa Walter
Stock Analyst at RBC Capital
(1.82)
# 3,167
Out of 4,944 analysts
3
Total ratings
50%
Success rate
5.04%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lisa Walter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRDN Viridian Therapeutics | Maintains: Outperform | $45 → $41 | $17.97 | +128.16% | 1 | Aug 7, 2025 | |
| APLS Apellis Pharmaceuticals | Maintains: Sector Perform | $17 → $19 | $23.90 | -20.50% | 1 | Aug 1, 2025 | |
| EYPT EyePoint Pharmaceuticals | Initiates: Outperform | $28 | $10.75 | +160.47% | 1 | Jun 17, 2025 |
Viridian Therapeutics
Aug 7, 2025
Maintains: Outperform
Price Target: $45 → $41
Current: $17.97
Upside: +128.16%
Apellis Pharmaceuticals
Aug 1, 2025
Maintains: Sector Perform
Price Target: $17 → $19
Current: $23.90
Upside: -20.50%
EyePoint Pharmaceuticals
Jun 17, 2025
Initiates: Outperform
Price Target: $28
Current: $10.75
Upside: +160.47%